Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Spotlight on experiences of medicine unavailability: Access to medicines challenges for NCDs and NTDs - The contrasting cases of Insulin and Praziquantel.

Wells N, Chappuis F, Beran D. Expert review of clinical pharmacology. 2020;
Publication

Mass Drug Treatment of Tropical Diseases: Is It Really Progress?

Fong I. Springer International Publishing. Current Trends and Concerns in Infectious Diseases. 2020;
Publication

Factors associated with cutaneous ulcers among children in two yaws-endemic districts in Ghana.

Okine R, Sarfo B, Adanu R, et al. Infectious diseases of poverty. 2020; 9 (1) : 26.
Download PDF
Publication

Effects of Water Source, Sanitation and Hygiene on the Prevalence of Schistosoma mansoni among School Age Children in Jawe District, Northwest Ethiopia

Hailu T, Mulu W, Abera B. Iran J Parasitol. 2019;
Download PDF
Publication

Clinical and economic burden of wound care in the tropics: a 5-year institutional population health review.

Lo Z, Lim X, Eng D, et al. International wound journal. 2020;
Download PDF
Publication

Schistosomiasis and soil-transmitted helminthiasis preventive chemotherapy: Adverse events in children from 2 to 15 years in Bengo province, Angola.

Lemos M, Pedro J, Fançony C, et al. PloS one. 2020; 15 (3) : e0229247.
Download PDF
Publication

Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs

Turner H, French M, Montresor A, et al. F1000 Research Ltd. Wellcome Open Research. 2020;
Download PDF
Publication

A call to action for universal health coverage: Why we need to address gender inequities in the neglected tropical diseases community.

Ozano K, Dean L, Yoshimura M, et al. PLoS neglected tropical diseases. 2020; 14 (3) : e0007786.
Download PDF
Publication

Implementing civic engagement within mental health services in South East Asia: a systematic review and realist synthesis of current evidence.

James K, Brooks H, Susanti H, et al. International journal of mental health systems. 2020;
Download PDF
Publication

Report of the third WHO stakeholders meeting on gambiense human African trypanosomiasis elimination

WHO/Department of control of neglected tropical diseases . World Health Organization. 2020;
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 479
  • Page 480
  • Page 481
  • Page 482
  • Current page 483
  • Page 484
  • Page 485
  • Page 486
  • Page 487
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD